CAS 30544-61-7

Clanobutin

Description:

Clanobutin, with the CAS number 30544-61-7, is a chemical compound that belongs to the class of drugs known as bronchodilators. It is primarily used in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) due to its ability to relax bronchial smooth muscles, thereby facilitating easier breathing. Clanobutin exhibits a mechanism of action similar to that of other sympathomimetic agents, acting on beta-adrenergic receptors. The compound is characterized by its relatively low solubility in water, which can influence its bioavailability and pharmacokinetics. Additionally, it may have a range of side effects, including cardiovascular effects, which necessitate careful monitoring during use. As with many pharmacological agents, the specific dosage and administration guidelines are crucial for maximizing therapeutic benefits while minimizing potential risks. Overall, Clanobutin represents a significant option in the pharmacotherapy of obstructive airway diseases, although its use may be limited by regulatory status and availability in different regions.

Formula: C₁₈H₁₈ClNO₄

InChI: InChI=1/C18H18ClNO4/c1-24-16-10-8-15(9-11-16)20(12-2-3-17(21)22)18(23)13-4-6-14(19)7-5-13/h4-11H,2-3,12H2,1H3,(H,21,22)

InChI key: InChIKey=VUPBWNXFSDRWJE-UHFFFAOYSA-N

SMILES: N(C(=O)C1=CC=C(Cl)C=C1)(CCCC(O)=O)C2=CC=C(OC)C=C2

Synonyms:

• 4-((4-Chlorobenzoyl)(4-methoxyphenyl)amino)butanoic acid
• 4-(p-Chloro-N-(p-methoxyphenyl)benzamido)butyric acid
• B 6518
• Brn 2172135
• Butanoic acid, 4-((4-chlorobenzoyl)(4-methoxyphenyl)amino)- (9CI)
• Butanoic acid, 4-[(4-chlorobenzoyl)(4-methoxyphenyl)amino]-
• Butyric acid, 4-(p-chloro-N-(p-methoxyphenyl)benzamido)-
• Bykahepar
• Clanobutin [INN]
• Clanobutina
• Clanobutina [INN-Spanish]
• Clanobutine
• Clanobutine [INN-French]
• Clanobutinum
• Clanobutinum [INN-Latin]
• N-(p-Chlorbenzoyl)-gamma-(p-anisidino)-buttersaeure
• N-(p-Chlorbenzoyl)-gamma-(p-anisidino)-buttersaeure [German]
• N-(p-Chlorobenzoyl)-gamma-(p-anisidino)butyric acid
• N-(p-Chlorobenzoyl)-γ-(p-anisidino)butyric acid
• Unii-W6Y945055S
• Clanobutin
• 4-[(4-Chlorobenzoyl)(4-methoxyphenyl)amino]butyric acid
• Clanobutin sodiuM

Clanobutin

Controlled Product

CAS: 30544-61-7

Applications Clanobutin inhibits gluconeogenesis in isolated perfused rat livers. it is a a choleretic and digestion-stimulating agent for animals.
References Wolf, H., et al.: Biochem. Pharm., 29, 1649 (1980); Ahmed, H., et al.: Vet. Med. J. Giza, 37, 313 (1989)

Formula: C₁₈H₁₈ClNO₄

Color and Shape: White To Off-White

Molecular weight: 347.79

Ref: TR-C558000

Clanobutin-d4

Controlled Product

CAS: 30544-61-7

Applications Clanobutin-d4 is labelled Clanobutin (C558000) which inhibits gluconeogenesis in isolated perfused rat livers. it is a a choleretic and digestion-stimulating agent for animals.
References Wolf, H., et al.: Biochem. Pharm., 29, 1649 (1980); Ahmed, H., et al.: Vet. Med. J. Giza, 37, 313 (1989)

Formula: C₁₈H₁₄D₄ClNO₄

Color and Shape: Neat

Molecular weight: 351.82

Ref: TR-C558002

Clanobutin

CAS: 30544-61-7

Clanobutin is a drug that has been shown to have an inhibitory effect on fatty acid synthesis. It is used in the treatment of bowel disease, such as inflammatory bowel disease. This drug also has a profile that includes symptoms of occlusive ileitis and colitis in animals. Clanobutin inhibits the production of inflammatory substances by interfering with the process of lipid synthesis.

Formula: C₁₈H₁₈ClNO₄

Purity: Min. 95%

Molecular weight: 347.8 g/mol

Ref: 3D-FBA54461

Clanobutin

CAS: 30544-61-7

Clanobutin inhibits gluconeogenesis and acts as a choleretic and digestion-stimulating agent.

Formula: C₁₈H₁₈ClNO₄

Color and Shape: Solid

Molecular weight: 347.79

Ref: TM-T69481